The canonical inflammasome also plays a role in the pathogenesis of advanced AMD, and mycophenolate’s downregulatory effect on Il-1 beta is a third biologically plausible mechanism by which the drug could protect against conversion from dry to wet AMD. This evidence concerns the gene IL1B and age-related macular degeneration.